Healthy M&A Expected In Pharma-Life Sciences Sectors In 2024
In all probabilities, it is expected that mergers & acquisitions in the pharma and life sciences sectors will hit a healthy level in 2024, with deals reaching $225 billion to $275 billion, according to PwC’s new US Deals 2024 Outlook report. The report lays significance on the precision medicine opportunities across oncology along with immunology, […]
White House Asks Drugmakers To Pay Inflation Rebates Back
Pharma companies in the US have come under fire yet again from the White House. This is the second time in two weeks that such a scenario has taken place. The Biden administration announced that several of drugmakers would be asked to pay inflation rebates to the Centers for Medicare and Medicaid Services because of […]
ReciBioPharm partners with Acuitas Therapeutics to provide rapid technology transfers and CGMP manufacture of Acuitas LNP formulations
ReciBioPharm, the advanced and emerging therapies business unit within Recipharm, and biotechnology firm Acuitas Therapeutics have today announced they are taking their partnership to the next level, and are ready to perform technology transfers and CGMP manufacturing for customers licensing Acuitas’ lipid nanoparticle (LNP) formulations for mRNA-based therapeutics and vaccines. ReciBioPharm first partnered with Acuitas […]
“Machines & Medicine”: new podcast from Syntegon covers all important pharma topics
Conversations around everything related to the pharmaceutical industry Six episodes available on Spotify and YouTube: from Annex 1 to sustainability Many more exciting topics and guests from the industry planned for 2024 Waiblingen (Germany), December 13, 2023. The pharmaceutical industry faces regulations and challenges like no other. Drug manufacturers are subject to the highest quality […]
World Temperature-Controlled Pharma Packaging To Hit 945.2mn
In 2022, the global market for pharmaceutical temperature-controlled packaging solutions happened to be valued at USD 578.9 million. It is, in all probabilities, set to reach almost USD 945.2 million by 2030, with a CAGR of 6.30% from 2022 to 2030. It is well to be noted that the market for pharma temperature-controlled packaging solutions […]
US Federal & State Drug Pricing Posing Major Challenges
The pharmaceutical sector has gone on to face pressure as well as uncertainty in 2023, and that is in all likelihood going to continue in 2024, partially due to the execution as well as evolution of the Inflation Reduction Act- IRA. Meanwhile, states happen to be anticipating continuing their growingly aggressive endeavors so as to […]
Financial Elements Supporting & Challenging Pharma In 2024
As per the results of a study done by GlobalData, the top issues when it comes to the pharmaceutical industry in 2024 are going to be inflation, geopolitical conflict, as well as drug pricing pressures. Data outcomes went on to reveal that most respondents from the Pharma gamut considered that drug pricing as well as […]
500 Drugs Set To Witness A Price Hike In The US In Jan 2024
In a recent development, drugmakers such as Pfizer, Sanofi, as well as Takeda Pharmaceutical went on to plan to raise costs in the US when it comes to more than 500 drugs in early January 2024, according to data analysed by healthcare research firm 3 Axis Advisors and as reported by Reuters. Not including various […]
Modafinil In Focus: Understanding The Pros And Cons Of This Emerging Nootropic
In recent years, the world has witnessed an ever-growing interest in nootropics, compounds designed to enhance cognitive functions, with an increasing number of people choosing to buy nootropics from CosmicNootropic or similar reputable companies. Modafinil has risen as a standout in brain-boosting supplements as the race for a cognitive edge intensifies. A prescription medication known […]
Innovations Enhancing Cold Chain Packaging Solutions In 2024
As per the recent projections, the market when it comes to temperature-controlled packaging solutions is most likely to reach almost $26.2 billion by 2030, thereby showcasing a robust yearly growth rate of more than 11.2%. It is well to be noted that in 2024, one can anticipate to go through a major growth when it […]
